Andrea E. Reid, M.D., M.P.H.

Dr. Andrea Reid is an Associate Director of MAO and an instructor at Harvard Medical School. She completed her residency in Internal Medicine and a fellowship in Gastroenterology at MGH. An active advocate for aspiring minority physicians, she co-chaired the Internship Selection Committee for the department of Internal Medicine, and is currently involved in a hospital-wide mentorship initiative for all residents. Dr. Reid's interests include clinical outcomes and therapies of Hepatitis C and minority access to liver transplantation.

Andrea Reid, keynote speaker of the URM Medical Student Mentorship Program Networking Dinner on 10/26/06

Andrea Reid's publications.

1. Wise PH, First LR, Lamb GA, Kotelchuck M, Chen DW, Ewing A, Hersee H, Rideout J. Infant mortality increase despite high access to tertiary care: an evolving relationship among infant mortality, health care, and socioeconomic change. Pediatrics 1988;81:542-548.

2. Liang TJ, Reid AE, Xavier RJ, Cardiff RD, Wang TC. Transgenic expression of tpr-met oncogene leads to development of mammary hyperplasia and tumors. Journal of Clinical Investigation 1996;97:2872-2877.

3. Reid AE, Koziel MJ, Aiza I, Jeffers L, Reddy R, Schiff E, Dienstag JL, Lau JYN, Liang TJ. Hepatitis C virus genotypes, viremia, and hepatocellular carcinoma. American Journal of Gastroenterology 1999; 94:1619-1626.

4. Munoz SJ, Alter H, Nakatsuji Y, Shih JW-K. Reddy RK, Jeffers L, Schiff ER, Reid AE, Marrone A, Rothstein K, Manzarbeitia C, Liang TJ. The significance of Hepatitis G Virus in serum of patients with sporadic fulminant and subfulminant hepatitis of unknown etiology. Blood 1999;94:1460-1464.

5. McHutchinson JG, Poynard T, Pianko S, Gordon SC, Reid AE, Dienstag J, Morgan T, Yao R, Albrecht J for the International Hepatitis Interventional Therapy Group (HIT). The impact of interferon plus ribavirin on response to therapy in black patients with chronic hepatitis C.Gastroenterology 2000;119:1317-1323.

Reviews, Chapters, and Editorials

1. Reid AE, Liang TJ. The search for the ultimate screening test for hepatocellular carcinoma continues. Hepatology 1994;19:255-257.

2. Reid AE, Liang TJ. Tumor Marker for Metastasis: Searching for an Abnormal Needle in a Haystack. Hepatology 1994;20:1631-1634.

3. Reid AE, Friedman LS. Immunity to Hepatitis B Virus: Passing the Torch. Gastroenterology 1994;106:1388-1390.

Abstracts

1. Reid AE, Koziel MJ, Jeffers LJ, Reddy KR, Aiza I, Schiff ER, Dienstag JL, Liang TJ. Hepatitis C virus genotypes and hepatocellular carcinoma. Hepatology 1994;20:250A. 2. Reid AE, Hight AM, Chang Y, Weissman JS. Outcome of blacks with ESLD referred for liver transplantation. Hepatology 1999;30:664A. 3. Reid AE, Hight AM, Chang Y, Weissman JS. Regional variation in liver transplantation among blacks. Hepatology 1999;30:185A. 4. Talwalkar J, Lalan S, Hauser S, Grace N, Reid AE, Corasanti J, Fiarman G, Shaw-Stiffe T, Thiim M, Uchman S, Gollan J. Combination therapy with interfereon-alpha-2B (Intron-A) and ribavirin (Rebetrol) in chronic hepatitis C patients previously relapsing or not responding to therapy. Hepatology 1999;30:197A.

Other Published Material

1. Reid AE, Liang TJ. Association of Hepatitis C Virus and Hepatocellular Carcinoma in the United States. In: Proceedings of the 25th International Symposium of the Princess Takamatsu Cancer Research Fund. Princeton: Princeton Scientific Publishing Company, Inc., 1995: 41-49.

2. Reid AE, Dienstag JL. Viral Hepatitis. In Richman DD, Whitley RJ, Hayden FG (Eds): Clinical Virology. New York: Churchill Livingstone, 1996: 69-88.